Covered recipient · General Payments record
MOTI L TIKU
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$3,765.86
- Reported across 265 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $831.72 | 55 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $232.74 | 15 |
| ABBVIE INC. | $184.11 | 15 |
| UCB, Inc. | $136.74 | 9 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $117.03 | 6 |
| Janssen Biotech, Inc. | $83.29 | 5 |
| Lilly USA, LLC | $47.68 | 3 |
| Mallinckrodt Hospital Products Inc. | $16.71 | 1 |
| SOBI, INC | $13.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.08 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225889 | CMS |
| ABBVIE INC. | $4.31 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225891 | CMS |
| ABBVIE INC. | $10.62 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225893 | CMS |
| ABBVIE INC. | $14.13 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225895 | CMS |
| ABBVIE INC. | $15.89 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225897 | CMS |
| ABBVIE INC. | $5.09 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225899 | CMS |
| ABBVIE INC. | $10.66 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225901 | CMS |
| ABBVIE INC. | $16.32 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225903 | CMS |
| ABBVIE INC. | $17.53 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225905 | CMS |
| ABBVIE INC. | $14.56 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225907 | CMS |
| ABBVIE INC. | $12.14 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225909 | CMS |
| ABBVIE INC. | $13.08 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225911 | CMS |
| ABBVIE INC. | $13.23 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225913 | CMS |
| ABBVIE INC. | $10.31 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225915 | CMS |
| ABBVIE INC. | $13.16 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225917 | CMS |
| Amgen Inc. | $16.84 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178593 | CMS |
| Amgen Inc. | $15.74 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178596 | CMS |
| Amgen Inc. | $15.74 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178601 | CMS |
| Amgen Inc. | $16.02 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178606 | CMS |
| Amgen Inc. | $15.29 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178573 | CMS |
| Amgen Inc. | $10.11 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178576 | CMS |
| Amgen Inc. | $13.92 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178611 | CMS |
| Amgen Inc. | $17.87 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178615 | CMS |
| Amgen Inc. | $14.37 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178580 | CMS |
| Amgen Inc. | $13.27 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178618 | CMS |
| Amgen Inc. | $17.29 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178584 | CMS |
| Amgen Inc. | $13.67 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117701416 | CMS |
| Amgen Inc. | $17.41 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178622 | CMS |
| Amgen Inc. | $18.75 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116178589 | CMS |
| Amgen Inc. | $16.45 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117701418 | CMS |
| Janssen Biotech, Inc. | $15.38 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078372474 | CMS |
| Janssen Biotech, Inc. | $15.94 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078372605 | CMS |
| Janssen Biotech, Inc. | $18.03 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373049 | CMS |
| Janssen Biotech, Inc. | $15.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078372970 | CMS |
| Janssen Biotech, Inc. | $18.31 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078372733 | CMS |
| Lilly USA, LLC | $15.17 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135208525 | CMS |
| Lilly USA, LLC | $13.66 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135223219 | CMS |
| Lilly USA, LLC | $18.85 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135255027 | CMS |
| Mallinckrodt Hospital Products Inc. | $16.71 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145145411 | CMS |
| Novartis Pharmaceuticals Corporation | $20.58 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428286 | CMS |
| Novartis Pharmaceuticals Corporation | $18.01 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428288 | CMS |
| Novartis Pharmaceuticals Corporation | $19.72 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428290 | CMS |
| Novartis Pharmaceuticals Corporation | $21.91 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428292 | CMS |
| Novartis Pharmaceuticals Corporation | $21.91 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428294 | CMS |
| Novartis Pharmaceuticals Corporation | $14.90 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087428296 | CMS |
| SOBI, INC | $13.42 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141420498 | CMS |
| UCB, Inc. | $10.60 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393693 | CMS |
| UCB, Inc. | $15.45 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393698 | CMS |
| UCB, Inc. | $10.49 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393702 | CMS |
| UCB, Inc. | $17.57 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393707 | CMS |
| UCB, Inc. | $12.41 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393711 | CMS |
| UCB, Inc. | $18.22 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393716 | CMS |
| UCB, Inc. | $14.53 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393720 | CMS |
| UCB, Inc. | $18.61 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393725 | CMS |
| UCB, Inc. | $18.86 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393729 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.